Hypoxia induces osteogenesis-related activities and expression of core binding factor α1 in mesenchymal stem cells

Tohoku Journal of Experimental Medicine

Volumn 224, Issue 1, 2011, Pages 7-12

  Huang, Jiao ^a   Deng, Feng ^a   Wang, Lu ^a   Xiang, Xue Rong ^a   Zhou, Wen Wen ^a   Hu, Na ^a   Xu, Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cbf 1; Differentiation; Hif 1 ; Hypoxia; Mesenchymal stem cells

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HYPOXIA; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL HYPOXIA; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RABBITS; RNA, MESSENGER;

EID: 79955498632     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.224.7     Document Type: Article

References (25)

1. Augello, A. & De Bari, C. (2010) The regulation of differentiation in mesenchymal stem cells. Hum. Gene Ther., 21, 1226-1238.
2. Chung, D.J., Hayashi, K., Toupadakis, C.A., Wong, A. & Yellowley, C.E. (2010) Osteogenic proliferation and differentiation of canine bone marrow and adipose tissue derived mesenchymal stromal cells and the infuence of hypoxia. Res. Vet. Sci., (in press).
3. Granero-Molto, F., Weis, J.A., Longobardi, L. & Spagnoli, A. (2008) Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin. Biol. Ther., 8, 255-268.
4. Haddad, J. & Harb, H. (2005) Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. Int. Immunopharmacol., 5, 461-483.
5. Harris, A.L. (2002) Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer, 2, 38-47.
6. Huang, Z., Ren, P.G., Ma, T., Smith, R.L. & Goodman, S.B. (2010) Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine, 51, 305-310.
7. Le, Q.T., Denko, N.C. & Giaccia, A.J. (2004) Hypoxic gene expression and metastasis. Cancer Metastasis Rev., 23, 293-310.
8. Lee, K.D., Kuo, T.K., Whang-Peng, J., Chung, Y.F., Lin, C.T., Chou, S.H., Chen, J.R., Chen, Y.P. & Lee, O.K. (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology, 40, 1275-1284.
9. Liu, L., Yu, Q., Lin, J., Lai, X., Cao, W., Du, K., Wang, Y., Wu, K., Hu, Y., Zhang, L., Xiao, H., Duan, Y. & Huang, H. (2011) HIF-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem. Cells Dev., In press.
10. Mikami, Y., Ishii, Y., Watanabe, N., Shirakawa, T., Suzuki, S., Irie, S., Isokawa, K. & Honda, M.J. (2011) CD271/p75(NTR) Inhibits the differentiation of mesenchymal stem cells into osteogenic, adipogenic, chondrogenic, and myogenic lineages. Stem. Cells Dev., [Epub ahead of print].
11. Mohyeldin, A., Garzón-Muvdi, T. & Quiñones-Hinojosa, A. (2010) Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem. Cell, 7, 150-161.
12. Nagano, M., Kimura, K., Yamashita, T., Ohneda, K., Nozawa, D., Hamada, H., Yoshikawa, H., Ochiai, N. & Ohneda, O. (2010) Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair. Stem. Cells Dev., 19, 1195-1210.
13. Nekanti, U., Dastidar, S., Venugopal, P., Totey, S. & Ta, M. (2010) Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia. Int. J. Biol. Sci., 6, 499-512.
14. Otto, W.R. & Rao, J. (2004) Tomorrow's skeleton staff: mesen-chymal stem cells and the repair of bone and cartilage. Cell Prolif., 37, 97-110.
15. Park, J.H., Park, B.H., Kim, H.K., Park, T.S. & Baek, H.S. (2002) Hypoxia decreases Runx2/Cbfα 1 expression in human osteo-blast-like cells. Mol. Cell. Endocrinol, 192, 197-203.
16. Peerani, R. & Zandstra, P.W. (2010) Enabling stem cell therapies through synthetic stem cell-niche engineering. J. Clin. Invest., 120, 60-70.
17. Pieter, J., Emansa, F.S., Don, A.M., Keryn, M.R., Andy, C, Lodewijk, W.R., Sjoerd, K.B., Willem, V. & Roel, K. (2007) A novel in vivo model to study endochondral bone formation; HIF-1 α activation and BMP expression. Bone, 40, 409-418.
18. Potier, E., Ferreira, E., Andriamanalijaona, R., Pujol, J.P., Oudina, K., Logeart-Avramoglou, D. & Petite, H. (2007) Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone, 40, 1078-1087.
19. Qi, M.C., Zou, S.J., Han, L.C., Zhou, H.X. & Hu, J. (2009) Expression of bone-related genes in bone marrow MSCs after cyclic mechanical strain: implications for distraction osteogenesis. Int. J. Oral Sci., 1, 143-150.
20. Rabie, A.B., Tang, G.H. & Hägg, U. (2004) Cbfa1 couples chondrocytes maturation and endochondral ossification in rat mandibular condylar cartilage. Arch. Oral Biol, 49, 109-118.
21. Santilli, G., Lamorte, G., Carlessi, L., Ferrari, D., Rota, N.L., Binda, E., Delia, D., Vescovi, A.L. & Filippis, L. (2010) Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS One, 5, e8575.
22. Seong, J.M., Kim, B.C., Park, J.H., Kwon, I.K., Mantalaris, A. & Hwang, Y.S. (2010) Stem cells in bone tissue engineering. Biomed. Mater, 5, 062001.
23. Wan, C, Shao, J., Gilbert, S.R., Riddle, R.C., Long, F., Johnson, R.S., Schipani, E. & Clemens, T.L. (2010) Role of HIF-1 α in skeletal development. Ann. N.Y. Acad. Sci., 1192, 322-326.
24. Zelzer, E., Glotzer, D.J., Hartmann, C, Thomas, D., Fukai, N., Soker, S. & Olsen, B.R. (2001) Tissue specifc regulation of VEGF expression during bone development requires Cbfα 1/ Runx2. Mech. Dev., 106, 97-106.
25. Zhao, Z.G., Zhao, S.M., Xu, N., Liu, X.Y., Liao, W.Q. & Jia, W. (2010) Lovastatin improves neurological outcome, reduces neurodegeneration, enhances M/NMDA receptor binding activity after nucleus basalis magnocellularis lesion in rats. Neuroscience, 167, 954-963.